Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition for treating leucopenia caused by radiotherapy

A leukopenia and composition technology, which is applied in drug combinations, extracellular fluid diseases, pharmaceutical formulations, etc., can solve problems affecting patient treatment and quality of life, stimulating malignant cell growth, and clinical application limitations, so as to maintain the continuity of radiotherapy , Improving immunity, no adverse reactions

Inactive Publication Date: 2016-05-04
QINGDAO HUAZHICAO PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chemotherapy and radiotherapy are currently the main means of treating tumors, but their serious side effects such as hair loss, impaired immunity, leukopenia, etc., have seriously affected the patient's treatment and quality of life
In recent years, colony-stimulating factors are often used as adjuvant therapy for the treatment of leukopenia caused by chemotherapy drugs. This type of drug has a significant effect but is relatively expensive, with short acting time, unstable curative effect, and relatively large side effects.
Publicly reported colony-stimulating factors may not only cause side effects such as bone pain, flu-like symptoms, fever, and leukopenia after drug withdrawal, but may also stimulate the growth of certain malignant cells, which limits clinical application to a certain extent.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating leucopenia caused by radiotherapy
  • Traditional Chinese medicine composition for treating leucopenia caused by radiotherapy
  • Traditional Chinese medicine composition for treating leucopenia caused by radiotherapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Take each raw material of the present invention by following weight parts:

[0034] 80 parts of ginseng, 60 parts of Codonopsis, 20 parts of turtle shell, 40 parts of white peony, 20 parts of ginger, 20 parts of papaya, 30 parts of Poria cocos, 80 parts of Sanleng, and 80 parts of Acanthopanax.

Embodiment 2

[0036] Take each raw material of the present invention by following weight parts:

[0037] 60 parts of ginseng, 80 parts of Codonopsis, 50 parts of turtle shell, 20 parts of white peony, 10 parts of ginger, 40 parts of papaya, 20 parts of Poria cocos, 80 parts of Sanleng, and 120 parts of Acanthopanax.

Embodiment 3

[0039] Take each raw material of the present invention by following weight parts:

[0040] 100 parts of ginseng, 40 parts of codonopsis, 40 parts of turtle shell, 60 parts of white peony, 40 parts of ginger, 40 parts of papaya, 20 parts of Poria cocos, 100 parts of Sanleng, and 100 parts of Acanthopanax.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of traditional Chinese medicine and relates to a traditional Chinese medicine composition for treating leucopenia caused by radiotherapy. The medicine composition is prepared from ginseng, radix codonopsis, turtle shells, radix paeoniae alba, ginger, pawpaw fruits, poria cocos, rhizoma sparganii and acanthopanax roots. The traditional Chinese medicine composition is prepared from the nine kinds of medicine materials according to a certain compatibility relation, and the nine kinds of medicine materials can jointly tonify qi and strength the foundation, strengthen the spleen and tonify the kidneys, nourish the blood and promote the blood circulation, tonify kidney-yin and nourish the bone marrow, and strength the body resistance to eliminate evil; the traditional Chinese medicine composition can balance organism functions, enhance the habitus of a patient and improve the immunity, the patient can maintain continuity of radiotherapy, and the treatment effect and the living quality of the patient can be improved.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition for treating leukopenia caused by radiotherapy. Background technique [0002] Tumor has become one of the main diseases that endanger human health. Patients with malignant tumors have low immunity, and their immunity will be even lower after radiotherapy. Current chemotherapy and radiotherapy are the main means of treating tumors, but their serious side effects such as hair loss, impaired immunity, and leukopenia have seriously affected the patient's treatment and quality of life. In recent years, the treatment of leukopenia caused by chemotherapeutic drugs often uses colony-stimulating factors as adjuvant therapy. This type of drug has a significant effect but is relatively expensive, with short-term action time, unstable curative effect, and relatively large side effects. Publicly reported colony-stimulating factor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61P7/00A61K35/586
CPCA61K35/586A61K36/076A61K36/254A61K36/258A61K36/344A61K36/65A61K36/71A61K36/732A61K36/902A61K36/9068A61K2300/00
Inventor 刘学键
Owner QINGDAO HUAZHICAO PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products